论文部分内容阅读
约10～20%的结节病患者应用皮质类固醇治疗后仍然发展至弥漫性肺纤维化,引起肺动脉高压和呼吸衰竭。作者对Ⅱ、Ⅲ期结节病患者用皮质类固醇治疗12个月,研究其对肺血液动力学的影响。病人和方法 24例Ⅱ、Ⅲ期结节病患者,经典型
About 10 to 20% of sarcoidosis patients still develop diffuse pulmonary fibrosis after treatment with corticosteroids, causing pulmonary hypertension and respiratory failure. The authors of Ⅱ, Ⅲ sarcoidosis patients treated with corticosteroids for 12 months to study its impact on pulmonary hemodynamics. Patients and Methods Twenty-four patients with stage II and III sarcoidosis were classic